All In MedTech

FDA Clearance Tracker · P160017-S122

MiniMed 770G System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 20, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 20, 2025

Approved

Time to decision

180 days

Received Feb 21, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P160017-S122
Device name
MiniMed 770G System
Applicant location
Northridge, CA
Received
Feb 21, 2025
Decided
Aug 20, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P160017

Device type

Device class
Class III

Every decision under product code OZP

FDA's approval statement

As written in FDA's record.

Approval for modified labeling for the MiniMed 770G System to include descriptive results of the post-approval study previously mandated under the approval order of P160017.

Source documents

Other decisions for Medtronic Minimed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.